The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Pediatric Neuroblastoma Treatment Market Research Report 2025

Global Pediatric Neuroblastoma Treatment Market Research Report 2025

Publishing Date : Mar, 2025

License Type :
 

Report Code : 1934361

No of Pages : 74

Ask Your Query
Synopsis
The global Pediatric Neuroblastoma Treatment market was valued at US$ 596.2 million in 2023 and is anticipated to reach US$ 867.1 million by 2030, witnessing a CAGR of 5.0% during the forecast period 2024-2030.
In terms of therapy type, the market has been classified into immunotherapy, chemotherapy, and others. The chemotherapy segment held leading market share in 2017.
This report aims to provide a comprehensive presentation of the global market for Pediatric Neuroblastoma Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pediatric Neuroblastoma Treatment.
Report Scope
The Pediatric Neuroblastoma Treatment market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Pediatric Neuroblastoma Treatment market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Pediatric Neuroblastoma Treatment companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
United Therapeutics
Apeiron Biologics
Pfizer
Bayer
Baxter
Cellectar Biosciences
MacroGenics
Segment by Type
Immunotherapy
Chemotherapy
Others
Segment by Application
Hospitals
Clinics
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Pediatric Neuroblastoma Treatment companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Pediatric Neuroblastoma Treatment Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Immunotherapy
1.2.3 Chemotherapy
1.2.4 Others
1.3 Market by Application
1.3.1 Global Pediatric Neuroblastoma Treatment Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Pediatric Neuroblastoma Treatment Market Perspective (2019-2030)
2.2 Pediatric Neuroblastoma Treatment Growth Trends by Region
2.2.1 Global Pediatric Neuroblastoma Treatment Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Pediatric Neuroblastoma Treatment Historic Market Size by Region (2019-2024)
2.2.3 Pediatric Neuroblastoma Treatment Forecasted Market Size by Region (2025-2030)
2.3 Pediatric Neuroblastoma Treatment Market Dynamics
2.3.1 Pediatric Neuroblastoma Treatment Industry Trends
2.3.2 Pediatric Neuroblastoma Treatment Market Drivers
2.3.3 Pediatric Neuroblastoma Treatment Market Challenges
2.3.4 Pediatric Neuroblastoma Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Pediatric Neuroblastoma Treatment Players by Revenue
3.1.1 Global Top Pediatric Neuroblastoma Treatment Players by Revenue (2019-2024)
3.1.2 Global Pediatric Neuroblastoma Treatment Revenue Market Share by Players (2019-2024)
3.2 Global Pediatric Neuroblastoma Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Pediatric Neuroblastoma Treatment Revenue
3.4 Global Pediatric Neuroblastoma Treatment Market Concentration Ratio
3.4.1 Global Pediatric Neuroblastoma Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Pediatric Neuroblastoma Treatment Revenue in 2023
3.5 Pediatric Neuroblastoma Treatment Key Players Head office and Area Served
3.6 Key Players Pediatric Neuroblastoma Treatment Product Solution and Service
3.7 Date of Enter into Pediatric Neuroblastoma Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Pediatric Neuroblastoma Treatment Breakdown Data by Type
4.1 Global Pediatric Neuroblastoma Treatment Historic Market Size by Type (2019-2024)
4.2 Global Pediatric Neuroblastoma Treatment Forecasted Market Size by Type (2025-2030)
5 Pediatric Neuroblastoma Treatment Breakdown Data by Application
5.1 Global Pediatric Neuroblastoma Treatment Historic Market Size by Application (2019-2024)
5.2 Global Pediatric Neuroblastoma Treatment Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Pediatric Neuroblastoma Treatment Market Size (2019-2030)
6.2 North America Pediatric Neuroblastoma Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Pediatric Neuroblastoma Treatment Market Size by Country (2019-2024)
6.4 North America Pediatric Neuroblastoma Treatment Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Pediatric Neuroblastoma Treatment Market Size (2019-2030)
7.2 Europe Pediatric Neuroblastoma Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Pediatric Neuroblastoma Treatment Market Size by Country (2019-2024)
7.4 Europe Pediatric Neuroblastoma Treatment Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Pediatric Neuroblastoma Treatment Market Size (2019-2030)
8.2 Asia-Pacific Pediatric Neuroblastoma Treatment Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Pediatric Neuroblastoma Treatment Market Size by Region (2019-2024)
8.4 Asia-Pacific Pediatric Neuroblastoma Treatment Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Pediatric Neuroblastoma Treatment Market Size (2019-2030)
9.2 Latin America Pediatric Neuroblastoma Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Pediatric Neuroblastoma Treatment Market Size by Country (2019-2024)
9.4 Latin America Pediatric Neuroblastoma Treatment Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Pediatric Neuroblastoma Treatment Market Size (2019-2030)
10.2 Middle East & Africa Pediatric Neuroblastoma Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Pediatric Neuroblastoma Treatment Market Size by Country (2019-2024)
10.4 Middle East & Africa Pediatric Neuroblastoma Treatment Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 United Therapeutics
11.1.1 United Therapeutics Company Detail
11.1.2 United Therapeutics Business Overview
11.1.3 United Therapeutics Pediatric Neuroblastoma Treatment Introduction
11.1.4 United Therapeutics Revenue in Pediatric Neuroblastoma Treatment Business (2019-2024)
11.1.5 United Therapeutics Recent Development
11.2 Apeiron Biologics
11.2.1 Apeiron Biologics Company Detail
11.2.2 Apeiron Biologics Business Overview
11.2.3 Apeiron Biologics Pediatric Neuroblastoma Treatment Introduction
11.2.4 Apeiron Biologics Revenue in Pediatric Neuroblastoma Treatment Business (2019-2024)
11.2.5 Apeiron Biologics Recent Development
11.3 Pfizer
11.3.1 Pfizer Company Detail
11.3.2 Pfizer Business Overview
11.3.3 Pfizer Pediatric Neuroblastoma Treatment Introduction
11.3.4 Pfizer Revenue in Pediatric Neuroblastoma Treatment Business (2019-2024)
11.3.5 Pfizer Recent Development
11.4 Bayer
11.4.1 Bayer Company Detail
11.4.2 Bayer Business Overview
11.4.3 Bayer Pediatric Neuroblastoma Treatment Introduction
11.4.4 Bayer Revenue in Pediatric Neuroblastoma Treatment Business (2019-2024)
11.4.5 Bayer Recent Development
11.5 Baxter
11.5.1 Baxter Company Detail
11.5.2 Baxter Business Overview
11.5.3 Baxter Pediatric Neuroblastoma Treatment Introduction
11.5.4 Baxter Revenue in Pediatric Neuroblastoma Treatment Business (2019-2024)
11.5.5 Baxter Recent Development
11.6 Cellectar Biosciences
11.6.1 Cellectar Biosciences Company Detail
11.6.2 Cellectar Biosciences Business Overview
11.6.3 Cellectar Biosciences Pediatric Neuroblastoma Treatment Introduction
11.6.4 Cellectar Biosciences Revenue in Pediatric Neuroblastoma Treatment Business (2019-2024)
11.6.5 Cellectar Biosciences Recent Development
11.7 MacroGenics
11.7.1 MacroGenics Company Detail
11.7.2 MacroGenics Business Overview
11.7.3 MacroGenics Pediatric Neuroblastoma Treatment Introduction
11.7.4 MacroGenics Revenue in Pediatric Neuroblastoma Treatment Business (2019-2024)
11.7.5 MacroGenics Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
List of Tables
Table 1. Global Pediatric Neuroblastoma Treatment Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Immunotherapy
Table 3. Key Players of Chemotherapy
Table 4. Key Players of Others
Table 5. Global Pediatric Neuroblastoma Treatment Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 6. Global Pediatric Neuroblastoma Treatment Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 7. Global Pediatric Neuroblastoma Treatment Market Size by Region (2019-2024) & (US$ Million)
Table 8. Global Pediatric Neuroblastoma Treatment Market Share by Region (2019-2024)
Table 9. Global Pediatric Neuroblastoma Treatment Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 10. Global Pediatric Neuroblastoma Treatment Market Share by Region (2025-2030)
Table 11. Pediatric Neuroblastoma Treatment Market Trends
Table 12. Pediatric Neuroblastoma Treatment Market Drivers
Table 13. Pediatric Neuroblastoma Treatment Market Challenges
Table 14. Pediatric Neuroblastoma Treatment Market Restraints
Table 15. Global Pediatric Neuroblastoma Treatment Revenue by Players (2019-2024) & (US$ Million)
Table 16. Global Pediatric Neuroblastoma Treatment Market Share by Players (2019-2024)
Table 17. Global Top Pediatric Neuroblastoma Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pediatric Neuroblastoma Treatment as of 2023)
Table 18. Ranking of Global Top Pediatric Neuroblastoma Treatment Companies by Revenue (US$ Million) in 2023
Table 19. Global 5 Largest Players Market Share by Pediatric Neuroblastoma Treatment Revenue (CR5 and HHI) & (2019-2024)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Pediatric Neuroblastoma Treatment Product Solution and Service
Table 22. Date of Enter into Pediatric Neuroblastoma Treatment Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Pediatric Neuroblastoma Treatment Market Size by Type (2019-2024) & (US$ Million)
Table 25. Global Pediatric Neuroblastoma Treatment Revenue Market Share by Type (2019-2024)
Table 26. Global Pediatric Neuroblastoma Treatment Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 27. Global Pediatric Neuroblastoma Treatment Revenue Market Share by Type (2025-2030)
Table 28. Global Pediatric Neuroblastoma Treatment Market Size by Application (2019-2024) & (US$ Million)
Table 29. Global Pediatric Neuroblastoma Treatment Revenue Market Share by Application (2019-2024)
Table 30. Global Pediatric Neuroblastoma Treatment Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 31. Global Pediatric Neuroblastoma Treatment Revenue Market Share by Application (2025-2030)
Table 32. North America Pediatric Neuroblastoma Treatment Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 33. North America Pediatric Neuroblastoma Treatment Market Size by Country (2019-2024) & (US$ Million)
Table 34. North America Pediatric Neuroblastoma Treatment Market Size by Country (2025-2030) & (US$ Million)
Table 35. Europe Pediatric Neuroblastoma Treatment Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 36. Europe Pediatric Neuroblastoma Treatment Market Size by Country (2019-2024) & (US$ Million)
Table 37. Europe Pediatric Neuroblastoma Treatment Market Size by Country (2025-2030) & (US$ Million)
Table 38. Asia-Pacific Pediatric Neuroblastoma Treatment Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 39. Asia-Pacific Pediatric Neuroblastoma Treatment Market Size by Region (2019-2024) & (US$ Million)
Table 40. Asia-Pacific Pediatric Neuroblastoma Treatment Market Size by Region (2025-2030) & (US$ Million)
Table 41. Latin America Pediatric Neuroblastoma Treatment Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 42. Latin America Pediatric Neuroblastoma Treatment Market Size by Country (2019-2024) & (US$ Million)
Table 43. Latin America Pediatric Neuroblastoma Treatment Market Size by Country (2025-2030) & (US$ Million)
Table 44. Middle East & Africa Pediatric Neuroblastoma Treatment Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 45. Middle East & Africa Pediatric Neuroblastoma Treatment Market Size by Country (2019-2024) & (US$ Million)
Table 46. Middle East & Africa Pediatric Neuroblastoma Treatment Market Size by Country (2025-2030) & (US$ Million)
Table 47. United Therapeutics Company Detail
Table 48. United Therapeutics Business Overview
Table 49. United Therapeutics Pediatric Neuroblastoma Treatment Product
Table 50. United Therapeutics Revenue in Pediatric Neuroblastoma Treatment Business (2019-2024) & (US$ Million)
Table 51. United Therapeutics Recent Development
Table 52. Apeiron Biologics Company Detail
Table 53. Apeiron Biologics Business Overview
Table 54. Apeiron Biologics Pediatric Neuroblastoma Treatment Product
Table 55. Apeiron Biologics Revenue in Pediatric Neuroblastoma Treatment Business (2019-2024) & (US$ Million)
Table 56. Apeiron Biologics Recent Development
Table 57. Pfizer Company Detail
Table 58. Pfizer Business Overview
Table 59. Pfizer Pediatric Neuroblastoma Treatment Product
Table 60. Pfizer Revenue in Pediatric Neuroblastoma Treatment Business (2019-2024) & (US$ Million)
Table 61. Pfizer Recent Development
Table 62. Bayer Company Detail
Table 63. Bayer Business Overview
Table 64. Bayer Pediatric Neuroblastoma Treatment Product
Table 65. Bayer Revenue in Pediatric Neuroblastoma Treatment Business (2019-2024) & (US$ Million)
Table 66. Bayer Recent Development
Table 67. Baxter Company Detail
Table 68. Baxter Business Overview
Table 69. Baxter Pediatric Neuroblastoma Treatment Product
Table 70. Baxter Revenue in Pediatric Neuroblastoma Treatment Business (2019-2024) & (US$ Million)
Table 71. Baxter Recent Development
Table 72. Cellectar Biosciences Company Detail
Table 73. Cellectar Biosciences Business Overview
Table 74. Cellectar Biosciences Pediatric Neuroblastoma Treatment Product
Table 75. Cellectar Biosciences Revenue in Pediatric Neuroblastoma Treatment Business (2019-2024) & (US$ Million)
Table 76. Cellectar Biosciences Recent Development
Table 77. MacroGenics Company Detail
Table 78. MacroGenics Business Overview
Table 79. MacroGenics Pediatric Neuroblastoma Treatment Product
Table 80. MacroGenics Revenue in Pediatric Neuroblastoma Treatment Business (2019-2024) & (US$ Million)
Table 81. MacroGenics Recent Development
Table 82. Research Programs/Design for This Report
Table 83. Key Data Information from Secondary Sources
Table 84. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Pediatric Neuroblastoma Treatment Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Pediatric Neuroblastoma Treatment Market Share by Type: 2023 VS 2030
Figure 3. Immunotherapy Features
Figure 4. Chemotherapy Features
Figure 5. Others Features
Figure 6. Global Pediatric Neuroblastoma Treatment Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 7. Global Pediatric Neuroblastoma Treatment Market Share by Application: 2023 VS 2030
Figure 8. Hospitals Case Studies
Figure 9. Clinics Case Studies
Figure 10. Others Case Studies
Figure 11. Pediatric Neuroblastoma Treatment Report Years Considered
Figure 12. Global Pediatric Neuroblastoma Treatment Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 13. Global Pediatric Neuroblastoma Treatment Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 14. Global Pediatric Neuroblastoma Treatment Market Share by Region: 2023 VS 2030
Figure 15. Global Pediatric Neuroblastoma Treatment Market Share by Players in 2023
Figure 16. Global Top Pediatric Neuroblastoma Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pediatric Neuroblastoma Treatment as of 2023)
Figure 17. The Top 10 and 5 Players Market Share by Pediatric Neuroblastoma Treatment Revenue in 2023
Figure 18. North America Pediatric Neuroblastoma Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 19. North America Pediatric Neuroblastoma Treatment Market Share by Country (2019-2030)
Figure 20. United States Pediatric Neuroblastoma Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 21. Canada Pediatric Neuroblastoma Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. Europe Pediatric Neuroblastoma Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. Europe Pediatric Neuroblastoma Treatment Market Share by Country (2019-2030)
Figure 24. Germany Pediatric Neuroblastoma Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. France Pediatric Neuroblastoma Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. U.K. Pediatric Neuroblastoma Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. Italy Pediatric Neuroblastoma Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Russia Pediatric Neuroblastoma Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Nordic Countries Pediatric Neuroblastoma Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Asia-Pacific Pediatric Neuroblastoma Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Asia-Pacific Pediatric Neuroblastoma Treatment Market Share by Region (2019-2030)
Figure 32. China Pediatric Neuroblastoma Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Japan Pediatric Neuroblastoma Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. South Korea Pediatric Neuroblastoma Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. Southeast Asia Pediatric Neuroblastoma Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. India Pediatric Neuroblastoma Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Australia Pediatric Neuroblastoma Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Latin America Pediatric Neuroblastoma Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Latin America Pediatric Neuroblastoma Treatment Market Share by Country (2019-2030)
Figure 40. Mexico Pediatric Neuroblastoma Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Brazil Pediatric Neuroblastoma Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Middle East & Africa Pediatric Neuroblastoma Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Middle East & Africa Pediatric Neuroblastoma Treatment Market Share by Country (2019-2030)
Figure 44. Turkey Pediatric Neuroblastoma Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Saudi Arabia Pediatric Neuroblastoma Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. United Therapeutics Revenue Growth Rate in Pediatric Neuroblastoma Treatment Business (2019-2024)
Figure 47. Apeiron Biologics Revenue Growth Rate in Pediatric Neuroblastoma Treatment Business (2019-2024)
Figure 48. Pfizer Revenue Growth Rate in Pediatric Neuroblastoma Treatment Business (2019-2024)
Figure 49. Bayer Revenue Growth Rate in Pediatric Neuroblastoma Treatment Business (2019-2024)
Figure 50. Baxter Revenue Growth Rate in Pediatric Neuroblastoma Treatment Business (2019-2024)
Figure 51. Cellectar Biosciences Revenue Growth Rate in Pediatric Neuroblastoma Treatment Business (2019-2024)
Figure 52. MacroGenics Revenue Growth Rate in Pediatric Neuroblastoma Treatment Business (2019-2024)
Figure 53. Bottom-up and Top-down Approaches for This Report
Figure 54. Data Triangulation
Figure 55. Key Executives Interviewed

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock